跳至主要内容
临床试验/CTRI/2023/09/057265
CTRI/2023/09/057265尚未招募3 期

An Open Single-arm, Single-centric Clinical Trial on the therapeutic effectiveness of Varmam Therapy in the management of Otrai Thalai Vali (Migraine) - A pilot study - NI

ational Institute of Siddha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • History of five attacks lasting for 4-72 hours in the past 3 months
  • Patients having the symptoms of unilateral headache with pulsating quality, pain with mild to moderate intensity and aggravated by routine physical activity
  • Patients must have any one of the following symptoms,
  • Often accompanied by nausea (and/or vomiting)
  • Photophobia
  • Phonophobia
  • Patient who are willing to involve in the study by signing the consent and fulfilling the condition of performa
  • Patient who has Headache Impact Test total score 36-59 and Migraine Disability Assessment Test score 6-20

排除标准

  • K/C/O Cardiovascular disease.
  • K/C/O Trigeminal neuralgia
  • K/C/O Trauma
  • Patients with uncontrolled diabetes mellitus
  • Patients with uncontrolled hypertension
  • K/C/O Psychiatric diseases
  • K/C/O of Seizures
  • K/C/O Eye disease and uncorrected refractive errors
  • K/C/O cervical spondylosis

研究者

相似试验